###begin article-title 0
Two canine CD1a proteins are differentially expressed in skin
###end article-title 0
###begin p 1
###xml 120 136 120 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Canis familiaris</italic>
###xml 115 118 <span type="species:ncbi:9615">dog</span>
###xml 120 136 <span type="species:ncbi:9615">Canis familiaris</span>
###xml 1137 1142 <span type="species:ncbi:9606">human</span>
Lipid antigens are presented to T cells by the CD1 family of proteins. In this study, we characterize the complete dog (Canis familiaris) CD1 locus, which is located on chromosome 38. The canine locus contains eight CD1A genes (canCD1A), of which five are pseudogenes, one canCD1B, one canCD1C, one canCD1D, and one canCD1E gene. In vivo expression of canine CD1 proteins was shown for canCD1a6, canCD1a8, and canCD1b, using a panel of anti-CD1 monoclonal antibodies (mAbs). CanCD1a6 and canCD1a8 are recognized by two distinct mAbs. Furthermore, we show differential transcription of the three canCD1A genes in canine tissues. In canine skin, the transcription level of canCD1A8 was higher than that of canCD1A6, and no transcription of canCD1A2 was detected. Based on protein modeling and protein sequence alignment, we predict that both canine CD1a proteins can bind different glycolipids in their groove. Besides differences in ectodomain structure, we observed the unique presence of three types of cytoplasmic tails encoded by canCD1A genes. cDNA sequencing and expressed sequence tag sequences confirmed the existence of a short, human CD1a-like cytoplasmic tail of four amino acids, of an intermediate length form of 15 amino acids, and of a long form of 31 amino acids.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">1994</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">1996</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">1998</xref>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2005</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">2007</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">2002</xref>
###xml 923 927 923 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2004</xref>
###xml 943 947 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">2005</xref>
###xml 1122 1126 1122 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">1994</xref>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">1997</xref>
###xml 1160 1164 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">1998</xref>
###xml 1179 1183 1179 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">2001</xref>
###xml 1640 1644 1640 1644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">1996</xref>
###xml 1661 1665 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">1998</xref>
###xml 1681 1685 1681 1685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">1999</xref>
###xml 1701 1705 1701 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">2000</xref>
###xml 1725 1729 1725 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2004</xref>
###xml 1745 1749 1745 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2007</xref>
###xml 1345 1350 <span type="species:ncbi:9606">Human</span>
###xml 1475 1480 <span type="species:ncbi:9606">Human</span>
Antigen presenting molecules play an important role in the adaptive immune system. The well-known major histocompatibility complex (MHC) class I and class II antigen-presenting molecules have been found in all jawed vertebrates studied so far. In mammals and birds, an additional antigen presenting lineage has been identified: the nonpolymorphic CD1 family of glycoproteins consisting of CD1a, CD1b, CD1c, CD1d, and CD1e. The remarkable difference between CD1 and MHC is that CD1 molecules present foreign and self-lipid antigens, rather than peptides to T cells (Beckman et al. 1994; Beckman et al. 1996; Spada et al. 1998; De Libero and Mori 2005; Barral and Brenner 2007). It has been shown that different classes of lipid antigens are presented by different CD1 isoforms. The small binding groove of CD1a allows the binding of mycobacterial lipopeptides and sulfatide sphingolipid (Shamshiev et al. 2002; Moody et al. 2004; Zajonc et al. 2005), whereas CD1b has the largest binding groove of all CD1 isoforms and is capable to bind lipid antigens with much longer alkyl chains, such as mycolyl lipids (Beckman et al. 1994; Moody et al. 1997; Ernst et al. 1998; Niazi et al. 2001). Not only the size and shape of the CD1 groove structure but also intracellular trafficking determines which lipid antigens are presented by which CD1 isoform. Human CD1a has been shown to traffic to early endosomes were it samples lipid antigens and translocates back to the cell surface. Human CD1b, CD1c, and CD1d traffic to lysosomes and/or late endosomal compartments within the cell where they encounter other types of lipid antigens (Sugita et al. 1996; Jackman et al. 1998; Sugita et al. 1999; Briken et al. 2000; Brigl and Brenner 2004; Sugita et al. 2007).
###end p 4
###begin p 5
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2007</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">1994</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">2000</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2003</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">2004</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">1995</xref>
###xml 810 814 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">1997</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">1997</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2002</xref>
###xml 207 212 <span type="species:ncbi:9606">Human</span>
Another difference between CD1 isoforms is their expression pattern and the type of T cell they activate. Group 1 CD1 molecules (CD1a, CD1b, and CD1c) are expressed on professional antigen-presenting cells. Human Langerhans cells in the skin are known for their high expression of CD1a, while dermal dendritic cells express CD1b and CD1c (Dougan et al. 2007). It has been shown that group 1 CD1 molecules present mycobacterial antigens to T cells (Beckman et al. 1994; Moody et al. 2000; Pena-Cruz et al. 2003; Moody et al. 2004). Group 2 CD1 molecules (CD1d) are expressed on several types of antigen-presenting cells but are also present on a wide range of nonhematopoietic cells. CD1d is the restricting element that selects and activates invariant natural killer T cells (Bendelac et al. 1995; Chen et al. 1997; Kawano et al. 1997; Gumperz et al. 2002).
###end p 5
###begin p 6
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1986</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">2001</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">1999</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 303 313 <span type="species:ncbi:10141">guinea pig</span>
The human CD1 locus contains one gene for each of the different CD1 isoforms (Calabi and Milstein 1986; Shiina et al. 2001). However, as a result of CD1 gene duplication and deletion during mammalian evolution, the number of CD1 molecules and their genes is different in other species. For example, the guinea pig CD1 locus consists of four CD1B genes and three CD1C genes. It is thought that the loss of CD1 isoform diversity and their specific function is at least partly recovered by gene duplication and neo-functionalization of CD1 molecules (Dascher et al. 1999).
###end p 6
###begin p 7
###xml 28 31 <span type="species:ncbi:9615">dog</span>
In this study, the complete dog CD1 locus is characterized. We show the differential expression of CD1A genes in canine skin and the unique in vivo expression of two distinct CD1a proteins.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
In silico identification of canine CD1 genes
###end title 9
###begin p 10
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 323 328 <span type="species:ncbi:9606">human</span>
###xml 341 347 <span type="species:ncbi:9986">rabbit</span>
###xml 373 376 <span type="species:ncbi:9823">pig</span>
###xml 393 399 <span type="species:ncbi:9913">cattle</span>
###xml 424 427 <span type="species:ncbi:9685">cat</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
###xml 532 537 <span type="species:ncbi:9606">human</span>
Blast searches in the canine genome (Broad Institute of MIT/Harvard, CanFam 2.0 version 46.2d; coverage 7.5), available at , were performed with alpha1 and alpha2 domain nucleotide sequences of all human CD1 isoforms. To compare canine CD1A genes with other mammalian CD1A genes, we used the known CD1A genes in GenBank of human (NM001763), rabbit (AF276977 and AF276978), pig (AF059492), and cattle (DQ192541). To identify cat CD1A genes, we performed a blast search with the human alpha1 and alpha2 domain nucleotide sequences of human CD1A in the feline genome (Agencourt Bioscience, CAT version 46.1b; coverage 2). Blast searches for expressed sequence tag (EST) sequences were performed at the National Center for Biotechnology Information website ().
###end p 10
###begin title 11
Canine tissue collection and cDNA synthesis
###end title 11
###begin p 12
###xml 48 52 <span type="species:ncbi:9615">dogs</span>
###xml 126 129 <span type="species:ncbi:9615">dog</span>
###xml 448 452 <span type="species:ncbi:9913">calf</span>
Tissue samples were obtained from healthy adult dogs (Beagles). Peripheral blood mononuclear cells (PBMCs) were isolated from dog blood by standard Ficoll-Hypaque gradient centrifugation. Skin samples were processed using a Biopulverizer and homogenized using a mini-Turrax (IKA). Intestine tissue (duodenum, jejunum, and colon) was washed and incubated in phosphate-buffered saline (PBS) with 0.75 mg/ml ethylenediamine tetraacetic acid, 5% fetal calf serum (FCS), and 50 mug/ml gentamicin at 37degreesC for 1 h to obtain intestinal cells. Single-cell suspensions were freshly prepared from the liver, spleen, lymph node, and thymus. Canine tissue was collected according to the regulations of the Animal Ethical Committee of the University of Utrecht, The Netherlands (protocol number 2007.II.06.152). From all collected tissues, ribonucleic acid (RNA) was isolated using the RNeasy kit (Qiagen) followed by complementary deoxyribonucleic acid (cDNA) synthesis with Multiscribe reverse transcriptase (Applied Biosystems).
###end p 12
###begin title 13
PCR, cloning, and sequence analysis
###end title 13
###begin p 14
###xml 1223 1224 1161 1162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">.</sc>
###xml 1298 1301 <span type="species:ncbi:9615">dog</span>
Polymerase chain reactions (PCRs) were performed with Pfu Turbo polymerase (Stratagene) according to the protocol of the manufacturer under the following cycling conditions: an initial denaturation of 7 min at 95degreesC, followed by 40 cycles of 15 s at 95degreesC, 45 s at a primer-specific annealing temperature, 30 s at 72degreesC, followed by a final elongation step of 5 min at 72degreesC. PCR for full-length CD1 genes was performed using thymus cDNA as a template and the following primers: canCD1A6 forward 5'-GCAAGAGAAAGACATCTGCAAACACG and reverse 5'-CCCTGGACTGACCTCAAGGCA at annealing temperature (Ta) of 61degreesC; canCD1A8 forward 5'-GCAAGAGAAAGACATCTGCAAACACG and reverse 5'-CACRGGGAGTGGCCAGGAC at Ta of 61degreesC; canCD1B forward 5'-CAGCCCACTGTCCGGGGAG and reverse 5'-AAGAAGAGTTCATGAGATGGCGAGGG at Ta of 61degreesC; canCD1C forward 5'-GGGAGCGGGGAAGCATCTGC and reverse 5'-GGGAGGCATGGTGACGAAGC at Ta of 59degreesC. The CD1D gene was not amplified in full length due to an unknown sequence upstream from the alpha2 domain sequence; therefore, canCD1D forward was designed in the alpha2 domain 5'-GATCCTGAGTTTCCAAGGGTCTCAC and reverse 5'-GCTGAGGGTGAAGAAAGGCTGC in the 3' untranslated region at Ta of 65degreesC. To determine the messenger RNA expression of the different CD1A genes in dog tissue, gene-specific forward primers and a general reverse primer were designed: canCD1A2 forward in alpha2 domain 5'-AGCTGCGCATTGGAGAACCTTTC; canCD1A6 forward in alpha1 domain 5'-GGACAGTGACTCTGGCACTTTCTTG; canCD1A8 forward in alpha1 domain 5'-CATACACCATCCGATCCCCTTCC; canCD1A general reverse primer in alpha3 domain 5'-AGACTGCTGTGTCTCACACGGC at a Ta of 59degreesC. Gel electrophoresis (10% agarose gel) was performed for 1 h at 100 V. After PCR, full-length CD1 PCR products were isolated from the gel. Products were ligated in a pCR4Blunt-TOPO vector (Invitrogen) to transform One Shot TOP10 cells (Invitrogen). Vector DNA of single colonies was sequenced by BaseClear (Leiden, The Netherlands). The obtained sequences were compared to the canine CD1 sequences obtained from the ensemble database (). The ExPASy Translate Tool was used () for translation into amino acids. All alignments were performed with ClustalW (align.genome.jp).
###end p 14
###begin title 15
Monoclonal antibodies and staining procedures
###end title 15
###begin p 16
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">1995</xref>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 729 734 <span type="species:ncbi:9606">Women</span>
###xml 797 802 <span type="species:ncbi:9606">human</span>
###xml 859 865 <span type="species:ncbi:9913">bovine</span>
###xml 945 952 <span type="species:ncbi:235354">Compton</span>
###xml 1030 1037 <span type="species:ncbi:235354">Compton</span>
###xml 1124 1128 <span type="species:ncbi:9925">Goat</span>
###xml 1134 1139 <span type="species:ncbi:10090">mouse</span>
The expression of CD1 by canine thymocytes, 030-D histiocytosis cell line (Levy et al. 1995), and 293T cells transfected with canCD1 was measured using a FACScalibur flow cytometer (Becton Dickinson). Transfection of 293T was performed with full-length CD1 gene sequences in pcDNA3.1+ vector (Invitrogen) using FuGENE6 (Roche) as transfection reagent. Anti-canine CD1 monoclonal antibodies (mAbs) CA13.9H11 (IgG1), CA9.AG5 (IgG1), anti-feline CD1a Fe1.5F4 (IgG1), and anti-feline CD1c Fe5.5C1 (IgG1) were provided by Dr. P.M. Moore (School of Veterinary Medicine, University of California, Davis, CA, USA). Anti-human CD1a (OKT6; IgG1), CD1b (BCD1b3; IgG1), and CD1c (F10/21A3; IgG1) were provided by Dr. D.B. Moody (Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA). Anti-human CD1a (WM-35; IgG2b) was obtained from ImmunoTools. Anti-bovine CD1 CC20 (IgG2a) was provided by Dr. C.J. Howard (Institute for Animal Health, Compton, UK); CC14 (IgG1) was provided by Dr. J.C. Hope (Institute for Animal Health Compton, UK); 20.27 SBU-T6 (IgG1) was obtained from the European Collection of Cell Cultures. Goat anti-mouse fluorescein isothiocyanate (GAM-FITC) was used as secondary antibody. Primary antibodies were diluted in PBS with 0.1% sodium azide and 2% FCS. Canine thymocytes, 030-D cell lines, and CD1-transfected 293T cells were incubated with primary antibody for 30 min at 4degreesC, followed by incubation with GAM-FITC (BD Biosciences) for 30 min at 4degreesC.
###end p 16
###begin title 17
Protein modeling
###end title 17
###begin p 18
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2001</xref>
###xml 76 81 <span type="species:ncbi:9606">human</span>
Canine CD1a protein models were generated using the Swiss Model Server with human CD1a (PDB code 1ONQ) as a template. The model was visualized using PyMol (pymol.sourceforge.net). The program APBS (Baker et al. 2001) was used to calculate the electrostatic surface potentials with electronegative in red and electropositive in blue (-30 to +30 kT/e).
###end p 18
###begin title 19
Results
###end title 19
###begin title 20
Characterization of the canine CD1 locus
###end title 20
###begin p 21
###xml 772 773 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 958 964 958 964 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1113 1117 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bold</italic>
###xml 1142 1151 1142 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">with &#936;.</italic>
###xml 1488 1496 1486 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asterisk</italic>
###xml 964 1600 964 1598 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="22">Complete gene map of the canine CD1 locus located on chromosome 38. Full-length canine CD1 genes without characteristics of pseudogenes are given in <italic>bold</italic>. Pseudogenes are marked <italic>with &#936;.</italic> Exact location of CD1 genes: CD1D: unknown&#8211;26502267; CD1A1: 26479022&#8211;26477829; CD1A2: 26470445&#8211;26467658; CD1A3: 26452485&#8211;26449619; CD1A4: 26439630&#8211;26436644; CD1A5: 26418868&#8211;26416544; CD1A6: 26398237&#8211;26395316; CD1A7: 26378486&#8211;26375657; CD1A8: 26363063&#8211;26360148; CD1B: 26332684&#8211;26329120; CD1C: 26344187&#8211;26341100; CD1E: 26310804&#8211;26308062. <italic>Asterisk</italic>, The location of the allelic variant of CD1A8 is: 81854142&#8211;81857071 on an unknown chromosome (Ensemble)</p>
###xml 964 1600 964 1598 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="22">Complete gene map of the canine CD1 locus located on chromosome 38. Full-length canine CD1 genes without characteristics of pseudogenes are given in <italic>bold</italic>. Pseudogenes are marked <italic>with &#936;.</italic> Exact location of CD1 genes: CD1D: unknown&#8211;26502267; CD1A1: 26479022&#8211;26477829; CD1A2: 26470445&#8211;26467658; CD1A3: 26452485&#8211;26449619; CD1A4: 26439630&#8211;26436644; CD1A5: 26418868&#8211;26416544; CD1A6: 26398237&#8211;26395316; CD1A7: 26378486&#8211;26375657; CD1A8: 26363063&#8211;26360148; CD1B: 26332684&#8211;26329120; CD1C: 26344187&#8211;26341100; CD1E: 26310804&#8211;26308062. <italic>Asterisk</italic>, The location of the allelic variant of CD1A8 is: 81854142&#8211;81857071 on an unknown chromosome (Ensemble)</p></caption>
###xml 1600 1600 1598 1598 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="251_2008_297_Fig1_HTML" id="MO1"/>
###xml 958 1600 958 1598 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="22">Complete gene map of the canine CD1 locus located on chromosome 38. Full-length canine CD1 genes without characteristics of pseudogenes are given in <italic>bold</italic>. Pseudogenes are marked <italic>with &#936;.</italic> Exact location of CD1 genes: CD1D: unknown&#8211;26502267; CD1A1: 26479022&#8211;26477829; CD1A2: 26470445&#8211;26467658; CD1A3: 26452485&#8211;26449619; CD1A4: 26439630&#8211;26436644; CD1A5: 26418868&#8211;26416544; CD1A6: 26398237&#8211;26395316; CD1A7: 26378486&#8211;26375657; CD1A8: 26363063&#8211;26360148; CD1B: 26332684&#8211;26329120; CD1C: 26344187&#8211;26341100; CD1E: 26310804&#8211;26308062. <italic>Asterisk</italic>, The location of the allelic variant of CD1A8 is: 81854142&#8211;81857071 on an unknown chromosome (Ensemble)</p></caption><graphic position="anchor" xlink:href="251_2008_297_Fig1_HTML" id="MO1"/></fig>
###xml 826 831 <span type="species:ncbi:9606">human</span>
###xml 872 877 <span type="species:ncbi:9606">human</span>
###xml 938 943 <span type="species:ncbi:9606">human</span>
The canine CD1 (canCD1) genes are located close to the telomeric end of chromosome 38 between 26.30 and 26.55 Mbp. The boundaries of the canCD1 locus are formed by the CD1-unrelated Kirrel and olfactory receptor gene group of which OR10T2 was the first gene adjacent to the CD1 locus. The canCD1 locus contains six gaps of 61-578 nucleotides, which are located between the CD1 genes, and one gap of 2,852 nucleotides that lies between base pairs 26,503,057 and 26,505,908 of which 75% of the nucleotide sequence was present in a draft sequence deposited by the Broad Institute (AC183576). The canCD1 locus consists of the following genes from the telomeric end to the centromere: one canCD1D gene, eight canCD1A genes, one canCD1C, one canCD1B, and one canCD1E gene (Fig. 1). The canine CD1 genes have the same orientation as human CD1 genes except for CD1B, which in the human CD1 locus has an opposite orientation compared to the other human CD1 isoforms. Fig. 1Complete gene map of the canine CD1 locus located on chromosome 38. Full-length canine CD1 genes without characteristics of pseudogenes are given in bold. Pseudogenes are marked with Psi. Exact location of CD1 genes: CD1D: unknown-26502267; CD1A1: 26479022-26477829; CD1A2: 26470445-26467658; CD1A3: 26452485-26449619; CD1A4: 26439630-26436644; CD1A5: 26418868-26416544; CD1A6: 26398237-26395316; CD1A7: 26378486-26375657; CD1A8: 26363063-26360148; CD1B: 26332684-26329120; CD1C: 26344187-26341100; CD1E: 26310804-26308062. Asterisk, The location of the allelic variant of CD1A8 is: 81854142-81857071 on an unknown chromosome (Ensemble)
###end p 21
###begin p 22
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bold</italic>
###xml 178 187 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">with &#936;.</italic>
###xml 524 532 522 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Asterisk</italic>
Complete gene map of the canine CD1 locus located on chromosome 38. Full-length canine CD1 genes without characteristics of pseudogenes are given in bold. Pseudogenes are marked with Psi. Exact location of CD1 genes: CD1D: unknown-26502267; CD1A1: 26479022-26477829; CD1A2: 26470445-26467658; CD1A3: 26452485-26449619; CD1A4: 26439630-26436644; CD1A5: 26418868-26416544; CD1A6: 26398237-26395316; CD1A7: 26378486-26375657; CD1A8: 26363063-26360148; CD1B: 26332684-26329120; CD1C: 26344187-26341100; CD1E: 26310804-26308062. Asterisk, The location of the allelic variant of CD1A8 is: 81854142-81857071 on an unknown chromosome (Ensemble)
###end p 22
###begin p 23
###xml 739 742 <span type="species:ncbi:9615">dog</span>
Of the eight CD1A genes, three CD1A genes (canCD1A2, canCD1A6, canCD1A8) revealed a complete sequence without obvious characteristics of pseudogenes like internal stop codons, frameshift mutations, and splice site mutations. Five CD1A genes were considered to be pseudogenes (canCD1A1, canCD1A3, canCD1A4, canCD1A5, canCD1A7). During the in silico study, we found a fourth full-length CD1A gene; however, due to its high nucleotide identity with canCD1A8 (93%) and because it was not assigned to chromosome 38 by Ensemble (CanFam 2.0, ), we assume that this is an allelic variation and named these two CD1A8 genes canCD1A8.1 and canCD1A8.2, accordingly. Furthermore, full-length genes for canCD1B, canCD1C, and canCD1E were present in the dog CD1 locus. In the draft sequence (AC183576), we found a part of the canine CD1D gene. In this sequence, it was not possible to identify the leader fragment, the first intron, and a small part of the alpha1 domain of canCD1D because the nucleotide sequence was unknown, but most of the alpha1 domain and the complete 3' part of the canCD1D gene were intact. Because the map of the locus is complete in the sense that the locus between the adjacent non-CD1 Kirrel and olfactory receptor genes did not contain any gaps big enough to contain a CD1 gene, we assume that we identified all canCD1 genes.
###end p 23
###begin title 24
Cloning of full-length canCD1 cDNAs
###end title 24
###begin p 25
###xml 1160 1163 <span type="species:ncbi:9615">dog</span>
###xml 1190 1193 <span type="species:ncbi:9615">dog</span>
Full-length cDNAs were cloned using a PCR-based strategy. The forward primer was designed to anneal upstream of the start codon, based on the available genomic sequences, and the reverse primer was designed to bind downstream of the predicted stop codon. Full-length canCD1A6 (GenBank EU373508/protein_id ACB12088) and canCD1A8.2 (GenBank EU373509/protein_id ACB12089) transcripts were cloned. We have not been able to obtain full-length CD1A2, which may be due to a low transcription level in thymus cDNA and high homology with canCD1A8 at the sites where the primers were designed to bind. The ectodomain of the canCD1A6 transcript was 97% identical at the amino acid level to the predicted canCD1A6 transcript from the in silico study. The canCD1A8 transcript showed greater amino acid identity to the predicted canCD1A8.2 transcript than to the predicted canCD1A8.1 transcript (98% and 88%, respectively). A single full-length canCD1B transcript was cloned (GenBank EU373510/protein_id ACB12090) and showed 99% amino acid identity with the predicted canCD1B. Two different full-length canCD1C transcripts were obtained from thymus-derived cDNA of a single dog (Beagle), which was named dog A. The two different transcripts canCD1C clone 1 and clone 2 (GenBank EU373511/protein_id ACB12091 and EU373512/protein_id ACB12092) both showed 98% amino acid identity to the predicted canCD1C transcript. These small nucleotide alterations compared to the predicted sequence might be caused by PCR artifacts and/or allelic variation. A third unique full-length canCD1C, clone 3 (GenBank EU373513/protein_id ACB12093), was obtained from cDNA derived from the 030-D canine histiocytosis cell line and showed 99% identity with the predicted canCD1C. From thymus-derived cDNA, a partial canCD1D transcript was cloned containing a fragment of the alpha2 domain, full-length alpha3 domain, a transmembrane region, and a cytoplasmic tail.
###end p 25
###begin title 26
Recognition of canCD1 molecules by monoclonal antibodies
###end title 26
###begin p 27
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1091 1097 1091 1097 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1207 1208 1207 1208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1209 1210 1209 1210 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1249 1250 1249 1250 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1251 1252 1251 1252 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1097 1364 1097 1364 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Flow cytometric analysis of expression canCD1 on tranfectant 293T cells. Cells are transfected with canCD1A6 (<bold>a</bold>&#8211;<bold>b</bold>) or with canCD1A8.2 gene transcripts (<bold>c</bold>&#8211;<bold>d</bold>). Staining was performed with anti-canine CD1 mAb CA13.9H11 and with anti-feline CD1a mAb, followed by GAM-FITC</p>
###xml 1097 1364 1097 1364 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Flow cytometric analysis of expression canCD1 on tranfectant 293T cells. Cells are transfected with canCD1A6 (<bold>a</bold>&#8211;<bold>b</bold>) or with canCD1A8.2 gene transcripts (<bold>c</bold>&#8211;<bold>d</bold>). Staining was performed with anti-canine CD1 mAb CA13.9H11 and with anti-feline CD1a mAb, followed by GAM-FITC</p></caption>
###xml 1364 1364 1364 1364 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="251_2008_297_Fig2_HTML" id="MO2"/>
###xml 1091 1364 1091 1364 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="28">Flow cytometric analysis of expression canCD1 on tranfectant 293T cells. Cells are transfected with canCD1A6 (<bold>a</bold>&#8211;<bold>b</bold>) or with canCD1A8.2 gene transcripts (<bold>c</bold>&#8211;<bold>d</bold>). Staining was performed with anti-canine CD1 mAb CA13.9H11 and with anti-feline CD1a mAb, followed by GAM-FITC</p></caption><graphic position="anchor" xlink:href="251_2008_297_Fig2_HTML" id="MO2"/></fig>
###xml 1364 1371 1364 1371 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1371 1519 1371 1519 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine histiocytosis cell line</p>
###xml 1371 1519 1371 1519 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine histiocytosis cell line</p></caption>
###xml 1519 1522 1519 1522 <th xmlns:xlink="http://www.w3.org/1999/xlink">mAb</th>
###xml 1522 1539 1522 1539 <th xmlns:xlink="http://www.w3.org/1999/xlink">Canine thymocytes</th>
###xml 1539 1544 1539 1544 <th xmlns:xlink="http://www.w3.org/1999/xlink">030-D</th>
###xml 1544 1552 1544 1552 <th xmlns:xlink="http://www.w3.org/1999/xlink">canCD1a6</th>
###xml 1552 1562 1552 1562 <th xmlns:xlink="http://www.w3.org/1999/xlink">canCD1a8.2</th>
###xml 1562 1569 1562 1569 <th xmlns:xlink="http://www.w3.org/1999/xlink">canCD1b</th>
###xml 1569 1589 1569 1589 <th xmlns:xlink="http://www.w3.org/1999/xlink">Published reactivity</th>
###xml 1589 1598 1589 1598 <th xmlns:xlink="http://www.w3.org/1999/xlink">Reference</th>
###xml 1519 1598 1519 1598 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>mAb</th><th>Canine thymocytes</th><th>030-D</th><th>canCD1a6</th><th>canCD1a8.2</th><th>canCD1b</th><th>Published reactivity</th><th>Reference</th></tr>
###xml 1519 1598 1519 1598 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>mAb</th><th>Canine thymocytes</th><th>030-D</th><th>canCD1a6</th><th>canCD1a8.2</th><th>canCD1b</th><th>Published reactivity</th><th>Reference</th></tr></thead>
###xml 1598 1607 1598 1607 <td xmlns:xlink="http://www.w3.org/1999/xlink">CA13.9H11</td>
###xml 1607 1608 1607 1608 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1608 1609 1608 1609 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1609 1610 1609 1610 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1610 1611 1610 1611 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1611 1612 1611 1612 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1612 1618 1612 1618 <td xmlns:xlink="http://www.w3.org/1999/xlink">canCD1</td>
###xml 1631 1635 1631 1635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">1996</xref>
###xml 1618 1635 1618 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td>
###xml 1598 1635 1598 1635 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CA13.9H11</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr>
###xml 1635 1642 1635 1642 <td xmlns:xlink="http://www.w3.org/1999/xlink">CA9.AG5</td>
###xml 1642 1643 1642 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1643 1644 1643 1644 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1644 1645 1644 1645 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1645 1646 1645 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1646 1647 1646 1647 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1647 1653 1647 1653 <td xmlns:xlink="http://www.w3.org/1999/xlink">canCD1</td>
###xml 1666 1670 1666 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">1996</xref>
###xml 1653 1670 1653 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink">Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td>
###xml 1635 1670 1635 1670 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CA9.AG5</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr>
###xml 1670 1675 1670 1675 <td xmlns:xlink="http://www.w3.org/1999/xlink">WM-35</td>
###xml 1675 1676 1675 1676 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1676 1677 1676 1677 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1677 1678 1677 1678 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1678 1679 1678 1679 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1679 1680 1679 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1680 1686 1680 1686 <td xmlns:xlink="http://www.w3.org/1999/xlink">huCD1a</td>
###xml 1686 1686 1686 1686 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1670 1686 1670 1686 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>WM-35</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>huCD1a</td><td/></tr>
###xml 1686 1692 1686 1692 <td xmlns:xlink="http://www.w3.org/1999/xlink">BCD1b3</td>
###xml 1692 1693 1692 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1693 1694 1693 1694 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1694 1695 1694 1695 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1695 1696 1695 1696 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1696 1697 1696 1697 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1697 1703 1697 1703 <td xmlns:xlink="http://www.w3.org/1999/xlink">huCD1b</td>
###xml 1703 1703 1703 1703 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1686 1703 1686 1703 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>BCD1b3</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>+</td><td>huCD1b</td><td/></tr>
###xml 1703 1708 1703 1708 <td xmlns:xlink="http://www.w3.org/1999/xlink">SBUT6</td>
###xml 1708 1709 1708 1709 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1709 1712 1709 1712 <td xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</td>
###xml 1712 1713 1712 1713 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1713 1714 1713 1714 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1714 1715 1714 1715 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1715 1729 1715 1729 <td xmlns:xlink="http://www.w3.org/1999/xlink">boCD1a/boCD1b3</td>
###xml 1743 1747 1743 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">1985</xref>
###xml 1729 1747 1729 1747 <td xmlns:xlink="http://www.w3.org/1999/xlink">Mackay et al. <xref ref-type="bibr" rid="CR23">1985</xref></td>
###xml 1703 1747 1703 1747 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>SBUT6</td><td>+</td><td>+/&#8722;</td><td>&#8722;</td><td>+</td><td>+</td><td>boCD1a/boCD1b3</td><td>Mackay et al. <xref ref-type="bibr" rid="CR23">1985</xref></td></tr>
###xml 1747 1751 1747 1751 <td xmlns:xlink="http://www.w3.org/1999/xlink">CC20</td>
###xml 1751 1752 1751 1752 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1752 1753 1752 1753 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1753 1754 1753 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1754 1755 1754 1755 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1755 1756 1755 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1756 1770 1756 1770 <td xmlns:xlink="http://www.w3.org/1999/xlink">huCD1b/boCD1b3</td>
###xml 1784 1788 1784 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">1993</xref>
###xml 1770 1788 1770 1788 <td xmlns:xlink="http://www.w3.org/1999/xlink">Howard et al. <xref ref-type="bibr" rid="CR18">1993</xref></td>
###xml 1747 1788 1747 1788 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>CC20</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>huCD1b/boCD1b3</td><td>Howard et al. <xref ref-type="bibr" rid="CR18">1993</xref></td></tr>
###xml 1788 1795 1788 1795 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fe1.5F4</td>
###xml 1795 1796 1795 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1796 1797 1796 1797 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1797 1798 1797 1798 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1798 1799 1798 1799 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1799 1800 1799 1800 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1800 1807 1800 1807 <td xmlns:xlink="http://www.w3.org/1999/xlink">felCD1a</td>
###xml 1821 1825 1821 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">1997</xref>
###xml 1807 1825 1807 1825 <td xmlns:xlink="http://www.w3.org/1999/xlink">Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td>
###xml 1788 1825 1788 1825 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fe1.5F4</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>felCD1a</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr>
###xml 1825 1832 1825 1832 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fe5.5C1</td>
###xml 1832 1833 1832 1833 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1833 1834 1833 1834 <td xmlns:xlink="http://www.w3.org/1999/xlink">+</td>
###xml 1834 1835 1834 1835 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1835 1836 1835 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1836 1837 1836 1837 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</td>
###xml 1837 1844 1837 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink">felCD1c</td>
###xml 1858 1862 1858 1862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">1997</xref>
###xml 1844 1862 1844 1862 <td xmlns:xlink="http://www.w3.org/1999/xlink">Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td>
###xml 1825 1862 1825 1862 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fe5.5C1</td><td>+</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>felCD1c</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr>
###xml 1598 1862 1598 1862 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>CA13.9H11</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>CA9.AG5</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>WM-35</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>huCD1a</td><td/></tr><tr><td>BCD1b3</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>+</td><td>huCD1b</td><td/></tr><tr><td>SBUT6</td><td>+</td><td>+/&#8722;</td><td>&#8722;</td><td>+</td><td>+</td><td>boCD1a/boCD1b3</td><td>Mackay et al. <xref ref-type="bibr" rid="CR23">1985</xref></td></tr><tr><td>CC20</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>huCD1b/boCD1b3</td><td>Howard et al. <xref ref-type="bibr" rid="CR18">1993</xref></td></tr><tr><td>Fe1.5F4</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>felCD1a</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr><tr><td>Fe5.5C1</td><td>+</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>felCD1c</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr></tbody>
###xml 1519 1862 1519 1862 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>mAb</th><th>Canine thymocytes</th><th>030-D</th><th>canCD1a6</th><th>canCD1a8.2</th><th>canCD1b</th><th>Published reactivity</th><th>Reference</th></tr></thead><tbody><tr><td>CA13.9H11</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>CA9.AG5</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>WM-35</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>huCD1a</td><td/></tr><tr><td>BCD1b3</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>+</td><td>huCD1b</td><td/></tr><tr><td>SBUT6</td><td>+</td><td>+/&#8722;</td><td>&#8722;</td><td>+</td><td>+</td><td>boCD1a/boCD1b3</td><td>Mackay et al. <xref ref-type="bibr" rid="CR23">1985</xref></td></tr><tr><td>CC20</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>huCD1b/boCD1b3</td><td>Howard et al. <xref ref-type="bibr" rid="CR18">1993</xref></td></tr><tr><td>Fe1.5F4</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>felCD1a</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr><tr><td>Fe5.5C1</td><td>+</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>felCD1c</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr></tbody></table>
###xml 1364 1862 1364 1862 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="29">A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine histiocytosis cell line</p></caption><table frame="hsides" rules="groups"><thead><tr><th>mAb</th><th>Canine thymocytes</th><th>030-D</th><th>canCD1a6</th><th>canCD1a8.2</th><th>canCD1b</th><th>Published reactivity</th><th>Reference</th></tr></thead><tbody><tr><td>CA13.9H11</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>CA9.AG5</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>canCD1</td><td>Moore et al. <xref ref-type="bibr" rid="CR27">1996</xref></td></tr><tr><td>WM-35</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>huCD1a</td><td/></tr><tr><td>BCD1b3</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>+</td><td>huCD1b</td><td/></tr><tr><td>SBUT6</td><td>+</td><td>+/&#8722;</td><td>&#8722;</td><td>+</td><td>+</td><td>boCD1a/boCD1b3</td><td>Mackay et al. <xref ref-type="bibr" rid="CR23">1985</xref></td></tr><tr><td>CC20</td><td>+</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>huCD1b/boCD1b3</td><td>Howard et al. <xref ref-type="bibr" rid="CR18">1993</xref></td></tr><tr><td>Fe1.5F4</td><td>+</td><td>&#8722;</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>felCD1a</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr><tr><td>Fe5.5C1</td><td>+</td><td>+</td><td>&#8722;</td><td>&#8722;</td><td>&#8722;</td><td>felCD1c</td><td>Woo and Moore <xref ref-type="bibr" rid="CR40">1997</xref></td></tr></tbody></table></table-wrap>
###xml 111 117 <span type="species:ncbi:9606">humans</span>
###xml 119 125 <span type="species:ncbi:9913">cattle</span>
###xml 127 132 <span type="species:ncbi:9940">sheep</span>
###xml 138 141 <span type="species:ncbi:9685">cat</span>
###xml 309 312 <span type="species:ncbi:9615">dog</span>
###xml 386 391 <span type="species:ncbi:9606">human</span>
###xml 413 419 <span type="species:ncbi:9913">bovine</span>
###xml 504 509 <span type="species:ncbi:9606">human</span>
###xml 534 539 <span type="species:ncbi:9606">human</span>
To determine which antibodies recognize the canine CD1 isoforms, we tested a panel of mAbs specific for CD1 in humans, cattle, sheep, and cat. We also tested the two anti-canine CD1 mAbs CA13.9H11 and CA9.AG5 for their specificity for canCD1. Results are summarized in Table 1. Freshly isolated thymocytes of dog A were recognized by the anti-canine mAb CA13.9H11 and CA9.AG5, the anti human mAb BCD1b3, the anti-bovine mAb CC20 and SBUT6, and the anti-feline mAb Fe1.5F4 and Fe5.5C1 but not by the anti-human CD1a mAb OKT-6 and anti-human CD1c mAb F10/21A3. Using 293T cells transfected with full-length canCD1 transcripts, we found that canCD1a6 is recognized by the anti-feline CD1a Fe1.5F4 but not by anti-canine CD1 CA13.9H11. The opposite was true for the recognition of canCD1a8.2 (Fig. 2). This implies that two different mAbs recognize two different in vivo expressed canCD1a proteins. The anti-canine CD1 antibody CA9.AG5 did not recognize canCD1a6, canCD1a8.2, and canCD1b protein on transfected 293T cells; however, it did recognize an unidentified epitope on canine thymocytes. Fig. 2Flow cytometric analysis of expression canCD1 on tranfectant 293T cells. Cells are transfected with canCD1A6 (a-b) or with canCD1A8.2 gene transcripts (c-d). Staining was performed with anti-canine CD1 mAb CA13.9H11 and with anti-feline CD1a mAb, followed by GAM-FITCTable 1A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine histiocytosis cell linemAbCanine thymocytes030-DcanCD1a6canCD1a8.2canCD1bPublished reactivityReferenceCA13.9H11++-+-canCD1Moore et al. 1996CA9.AG5+----canCD1Moore et al. 1996WM-35-+---huCD1aBCD1b3++-++huCD1bSBUT6++/--++boCD1a/boCD1b3Mackay et al. 1985CC20++-+-huCD1b/boCD1b3Howard et al. 1993Fe1.5F4+-+--felCD1aWoo and Moore 1997Fe5.5C1++---felCD1cWoo and Moore 1997
###end p 27
###begin p 28
###xml 110 111 110 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 112 113 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
Flow cytometric analysis of expression canCD1 on tranfectant 293T cells. Cells are transfected with canCD1A6 (a-b) or with canCD1A8.2 gene transcripts (c-d). Staining was performed with anti-canine CD1 mAb CA13.9H11 and with anti-feline CD1a mAb, followed by GAM-FITC
###end p 28
###begin p 29
A panel of anti-CD1 mAb was tested for recognition of canCD1 on transfectant 293T cells, canine thymocytes, and 030-D canine histiocytosis cell line
###end p 29
###begin p 30
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">1996</xref>
###xml 91 94 <span type="species:ncbi:9615">dog</span>
###xml 673 677 <span type="species:ncbi:9615">dogs</span>
###xml 817 820 <span type="species:ncbi:9615">dog</span>
293T cells transfected with the full-length canCD1C transcript clone 1 and 2, derived from dog A, or canCD1C transcript clone 3, derived from the 030-D cell line, were not recognized by any of the mAbs in this panel. Unfortunately, we have not been able to confirm expression of the three full-length canCD1c cDNAs by staining with any mAb or by alternative methods. The mAbs CA13.9H11 and CA9.AG5 have both been suggested to recognize canCD1 (Moore et al. 1996). In this study, we show that CA13.9H11 recognizes canCD1a8.2. We have not been able to show CD1 recognition by CA9.AG5. The mAb CA9.AG5 recognizes a molecule expressed on thymocytes of approximately 60% of all dogs, suggesting that this mAb is specific for an allotype or allelic variation of an unidentified gene product. In our study, the same animal (dog A) was used for flowcytometric analysis of ex vivo thymocytes and for cDNA synthesis from thymocytes. The ex vivo thymocytes of this animal were recognized by CA9.AG5, but the two slightly different CD1c cDNAs were not. This makes it unlikely that the lack of recognition by the anti-canine CD1 antibodies CA13.9H11 and CA9.AG5 is caused by allelic differences in canCD1c.
###end p 30
###begin title 31
Transcription of CD1A genes in different tissues
###end title 31
###begin p 32
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 563 569 563 569 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 569 705 569 702 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, &#946;-actin was included</p>
###xml 569 705 569 702 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, &#946;-actin was included</p></caption>
###xml 705 705 702 702 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="251_2008_297_Fig3_HTML" id="MO3"/>
###xml 563 705 563 702 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="33">Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, &#946;-actin was included</p></caption><graphic position="anchor" xlink:href="251_2008_297_Fig3_HTML" id="MO3"/></fig>
###xml 619 622 <span type="species:ncbi:9615">dog</span>
Transcription levels of the three different CD1A genes were determined in different tissues of a healthy Beagle. The expression of different CD1A genes in canine lymphoid and nonlymphoid tissues is shown in Fig. 3. The transcription of canCD1A2 was only found in the thymus, whereas canCD1A6 and canCD1A8 were transcribed in the thymus, lymph node, spleen, liver, skin, and PBMCs. It is interesting to note that, in skin, canCD1A8 is clearly expressed at a much higher level than the other CD1A genes. Results are representative of three independent experiments. Fig. 3Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, beta-actin was included
###end p 32
###begin p 33
###xml 50 53 <span type="species:ncbi:9615">dog</span>
Transcription of three canCD1A genes in different dog tissues. To be able to compare the quantity of input cDNA, beta-actin was included
###end p 33
###begin title 34
Comparison of canCD1a6 and canCD1a8 models and canine CD1 cytoplasmic tails
###end title 34
###begin p 35
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">2003</xref>
###xml 625 626 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">2005</xref>
###xml 1198 1200 1198 1200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">18</sub>
###xml 1244 1248 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">2003</xref>
###xml 1829 1835 1829 1835 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 1835 1836 1835 1836 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2230 2231 2222 2223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 2399 2402 2391 2394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 2427 2431 2419 2423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 2470 2471 2462 2463 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2595 2600 2587 2592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 2627 2635 2619 2627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in color</italic>
###xml 2705 2726 2697 2718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">highlighted in yellow</italic>
###xml 2839 2848 2831 2840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Darkgreen</italic>
###xml 2859 2864 2851 2856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 2924 2928 2916 2920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyan</italic>
###xml 2939 2943 2931 2935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 3021 3024 3013 3016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 3028 3032 3020 3024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 3064 3098 3056 3090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">highlighted but not colored in red</italic>
###xml 1835 3284 1835 3276 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36"><bold>a</bold> Molecular surface of human CD1a, canine CD1a6, and canine CD1a8. The &#945;1 and &#945;2 domains are depicted, and the opening to the binding groove is in the center of each molecule. Note that the bottom of the canCD1a6 binding groove appears electronegative due to the presence of Glu100; however, overall, the binding grove is hydrophobic. Furthermore, residue 100 is not highlighted in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>b, as it was not a residue contacting the sulfatide ligand in the human CD1a-sulfatide structure (1onq). Electrostatic potentials were calculated using APBS and PyMol; <italic>red</italic> is electronegative, and <italic>blue</italic> is electropositive (&#8722;30 to +30&#160;kT/e). <bold>b</bold> Multiple-sequence alignment (CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human CD1a, colored by sequence identity (<italic>black</italic>) and structural features (<italic>in color</italic>). Residues contributing to the CD1a binding groove of human CD1a are <italic>highlighted in yellow</italic>. These residues were originally identified base on their interaction with the sulfatide ligand (PDB code 1onq). <italic>Darkgreen</italic>, A&#8242; pole; <italic>green</italic>, terminal residue restricting the length of the A&#8242; pocket; <italic>cyan</italic>, A&#8242; roof; <italic>blue</italic>, residues at the opening to the CD1a groove (F&#8242; portal). Residues colored in <italic>red</italic> or <italic>gray</italic> are similar. Residues that are <italic>highlighted but not colored in red</italic> are predicted not to dramatically alter the structural feature. Canine residues not highlighted according to their human counterparts are predicted to have an altered structural element</p>
###xml 1835 3284 1835 3276 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36"><bold>a</bold> Molecular surface of human CD1a, canine CD1a6, and canine CD1a8. The &#945;1 and &#945;2 domains are depicted, and the opening to the binding groove is in the center of each molecule. Note that the bottom of the canCD1a6 binding groove appears electronegative due to the presence of Glu100; however, overall, the binding grove is hydrophobic. Furthermore, residue 100 is not highlighted in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>b, as it was not a residue contacting the sulfatide ligand in the human CD1a-sulfatide structure (1onq). Electrostatic potentials were calculated using APBS and PyMol; <italic>red</italic> is electronegative, and <italic>blue</italic> is electropositive (&#8722;30 to +30&#160;kT/e). <bold>b</bold> Multiple-sequence alignment (CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human CD1a, colored by sequence identity (<italic>black</italic>) and structural features (<italic>in color</italic>). Residues contributing to the CD1a binding groove of human CD1a are <italic>highlighted in yellow</italic>. These residues were originally identified base on their interaction with the sulfatide ligand (PDB code 1onq). <italic>Darkgreen</italic>, A&#8242; pole; <italic>green</italic>, terminal residue restricting the length of the A&#8242; pocket; <italic>cyan</italic>, A&#8242; roof; <italic>blue</italic>, residues at the opening to the CD1a groove (F&#8242; portal). Residues colored in <italic>red</italic> or <italic>gray</italic> are similar. Residues that are <italic>highlighted but not colored in red</italic> are predicted not to dramatically alter the structural feature. Canine residues not highlighted according to their human counterparts are predicted to have an altered structural element</p></caption>
###xml 3284 3284 3276 3276 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="251_2008_297_Fig4_HTML" id="MO4"/>
###xml 1829 3284 1829 3276 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="36"><bold>a</bold> Molecular surface of human CD1a, canine CD1a6, and canine CD1a8. The &#945;1 and &#945;2 domains are depicted, and the opening to the binding groove is in the center of each molecule. Note that the bottom of the canCD1a6 binding groove appears electronegative due to the presence of Glu100; however, overall, the binding grove is hydrophobic. Furthermore, residue 100 is not highlighted in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>b, as it was not a residue contacting the sulfatide ligand in the human CD1a-sulfatide structure (1onq). Electrostatic potentials were calculated using APBS and PyMol; <italic>red</italic> is electronegative, and <italic>blue</italic> is electropositive (&#8722;30 to +30&#160;kT/e). <bold>b</bold> Multiple-sequence alignment (CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human CD1a, colored by sequence identity (<italic>black</italic>) and structural features (<italic>in color</italic>). Residues contributing to the CD1a binding groove of human CD1a are <italic>highlighted in yellow</italic>. These residues were originally identified base on their interaction with the sulfatide ligand (PDB code 1onq). <italic>Darkgreen</italic>, A&#8242; pole; <italic>green</italic>, terminal residue restricting the length of the A&#8242; pocket; <italic>cyan</italic>, A&#8242; roof; <italic>blue</italic>, residues at the opening to the CD1a groove (F&#8242; portal). Residues colored in <italic>red</italic> or <italic>gray</italic> are similar. Residues that are <italic>highlighted but not colored in red</italic> are predicted not to dramatically alter the structural feature. Canine residues not highlighted according to their human counterparts are predicted to have an altered structural element</p></caption><graphic position="anchor" xlink:href="251_2008_297_Fig4_HTML" id="MO4"/></fig>
###xml 443 448 <span type="species:ncbi:9606">human</span>
###xml 601 606 <span type="species:ncbi:9606">human</span>
###xml 741 746 <span type="species:ncbi:9606">human</span>
###xml 1111 1116 <span type="species:ncbi:10090">mouse</span>
###xml 1218 1223 <span type="species:ncbi:9606">human</span>
###xml 1858 1863 <span type="species:ncbi:9606">human</span>
###xml 2297 2302 <span type="species:ncbi:9606">human</span>
###xml 2553 2558 <span type="species:ncbi:9606">human</span>
###xml 2690 2695 <span type="species:ncbi:9606">human</span>
###xml 3214 3219 <span type="species:ncbi:9606">human</span>
The protein sequence of the two different canCD1a molecules of which a full-length transcript was derived is very similar. However, single amino acid differences at key positions in the binding groove can result in noticeable differences in the structure of the binding groove and, moreover, in the ability to bind and present lipids. To predict whether the overall architecture of the antigen-binding grooves of canCD1a is similar to that of human CD1a, we generated models of the two in vivo expressed canCD1a molecules using the Swiss Model server (Schwede et al. 2003) and compared these to their human counterpart (Fig. 4a). Both the structural models and the sequence comparison (Fig. 4b) suggest that both canCD1a6 and canCD1a8, like human CD1a (Zajonc et al. 2005), have a hydrophobic binding groove with a buried A' pocket and a more exposed F' pocket. Key structural features such as the A' pole are conserved (Phe70 and Val/Ile12), as well as an A' roof is predicted (residues 66, 69, 161, 165). In addition, the A' pocket of canCD1a8 is predicted to be open ended (Gly28 vs. Val or Ala), similar to mouse CD1d. Therefore, the length of bound lipids in that pocket could be longer than C18, as observed for human CD1a (Zajonc et al. 2003). Clearly the shape of the individual pockets will be slightly different, as not all groove-lining residues are conserved. However, the overall size of the CD1a grooves appears to be similar. Furthermore, the groove opening of canCD1a8 appears slightly larger than the opening of canCD1a6. Furthermore, the residues lining the opening to the CD1a groove (F' portal) are the least conserved between the CD1a molecules. As these residues were shown to bind the glycolipid headgroup, we speculate that the three CD1a proteins have the capacity to bind different glycolipid antigens. Fig. 4a Molecular surface of human CD1a, canine CD1a6, and canine CD1a8. The alpha1 and alpha2 domains are depicted, and the opening to the binding groove is in the center of each molecule. Note that the bottom of the canCD1a6 binding groove appears electronegative due to the presence of Glu100; however, overall, the binding grove is hydrophobic. Furthermore, residue 100 is not highlighted in Fig. 5b, as it was not a residue contacting the sulfatide ligand in the human CD1a-sulfatide structure (1onq). Electrostatic potentials were calculated using APBS and PyMol; red is electronegative, and blue is electropositive (-30 to +30 kT/e). b Multiple-sequence alignment (CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human CD1a, colored by sequence identity (black) and structural features (in color). Residues contributing to the CD1a binding groove of human CD1a are highlighted in yellow. These residues were originally identified base on their interaction with the sulfatide ligand (PDB code 1onq). Darkgreen, A' pole; green, terminal residue restricting the length of the A' pocket; cyan, A' roof; blue, residues at the opening to the CD1a groove (F' portal). Residues colored in red or gray are similar. Residues that are highlighted but not colored in red are predicted not to dramatically alter the structural feature. Canine residues not highlighted according to their human counterparts are predicted to have an altered structural element
###end p 35
###begin p 36
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 395 396 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 564 567 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 592 596 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 635 636 627 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 760 765 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">black</italic>
###xml 792 800 784 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in color</italic>
###xml 870 891 862 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">highlighted in yellow</italic>
###xml 1004 1013 996 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Darkgreen</italic>
###xml 1024 1029 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green</italic>
###xml 1089 1093 1081 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cyan</italic>
###xml 1104 1108 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue</italic>
###xml 1186 1189 1178 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 1193 1197 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 1229 1263 1221 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">highlighted but not colored in red</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
###xml 855 860 <span type="species:ncbi:9606">human</span>
###xml 1379 1384 <span type="species:ncbi:9606">human</span>
a Molecular surface of human CD1a, canine CD1a6, and canine CD1a8. The alpha1 and alpha2 domains are depicted, and the opening to the binding groove is in the center of each molecule. Note that the bottom of the canCD1a6 binding groove appears electronegative due to the presence of Glu100; however, overall, the binding grove is hydrophobic. Furthermore, residue 100 is not highlighted in Fig. 5b, as it was not a residue contacting the sulfatide ligand in the human CD1a-sulfatide structure (1onq). Electrostatic potentials were calculated using APBS and PyMol; red is electronegative, and blue is electropositive (-30 to +30 kT/e). b Multiple-sequence alignment (CLUSTAL W 1.83) of canine CD1a isoforms 6 and 8 and human CD1a, colored by sequence identity (black) and structural features (in color). Residues contributing to the CD1a binding groove of human CD1a are highlighted in yellow. These residues were originally identified base on their interaction with the sulfatide ligand (PDB code 1onq). Darkgreen, A' pole; green, terminal residue restricting the length of the A' pocket; cyan, A' roof; blue, residues at the opening to the CD1a groove (F' portal). Residues colored in red or gray are similar. Residues that are highlighted but not colored in red are predicted not to dramatically alter the structural feature. Canine residues not highlighted according to their human counterparts are predicted to have an altered structural element
###end p 36
###begin p 37
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1164 1170 1164 1170 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 1170 1171 1170 1171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1370 1371 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1374 1375 1374 1375 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1518 1528 1518 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">underlined</italic>
###xml 1170 1528 1170 1528 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>a</bold> Alignment of the CD1a cytoplasmic tail sequences of different mammalian species. Tail sequences that were not confirmed by cDNA sequencing but only predicted from the genome are marked accordingly (<italic>p</italic>). <bold>b</bold> Alignment of cytoplasmic tail sequences of canCD1b, canCD1c, and canCD1d with their human orthologs. The tyrosine trafficking motif (YXXZ) is <italic>underlined</italic></p>
###xml 1170 1528 1170 1528 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>a</bold> Alignment of the CD1a cytoplasmic tail sequences of different mammalian species. Tail sequences that were not confirmed by cDNA sequencing but only predicted from the genome are marked accordingly (<italic>p</italic>). <bold>b</bold> Alignment of cytoplasmic tail sequences of canCD1b, canCD1c, and canCD1d with their human orthologs. The tyrosine trafficking motif (YXXZ) is <italic>underlined</italic></p></caption>
###xml 1528 1528 1528 1528 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="251_2008_297_Fig5_HTML" id="MO5"/>
###xml 1164 1528 1164 1528 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="38"><bold>a</bold> Alignment of the CD1a cytoplasmic tail sequences of different mammalian species. Tail sequences that were not confirmed by cDNA sequencing but only predicted from the genome are marked accordingly (<italic>p</italic>). <bold>b</bold> Alignment of cytoplasmic tail sequences of canCD1b, canCD1c, and canCD1d with their human orthologs. The tyrosine trafficking motif (YXXZ) is <italic>underlined</italic></p></caption><graphic position="anchor" xlink:href="251_2008_297_Fig5_HTML" id="MO5"/></fig>
###xml 351 354 <span type="species:ncbi:9685">cat</span>
###xml 480 483 <span type="species:ncbi:9685">cat</span>
###xml 642 647 <span type="species:ncbi:9606">human</span>
###xml 660 666 <span type="species:ncbi:9986">rabbit</span>
###xml 692 695 <span type="species:ncbi:9823">pig</span>
###xml 712 718 <span type="species:ncbi:9913">cattle</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
###xml 1460 1465 <span type="species:ncbi:9606">human</span>
Furthermore, different antigens are presented by CD1 proteins due to sampling in different endocytic compartments. This intracellular trafficking of CD1 is directed by the presence or absence of a sorting motif in the cytoplasmic tail. We aligned cytoplasmic tail sequences of the three canine CD1a proteins with the closely related carnivore species cat and to other, more distantly related mammalian species (Fig. 5a). To make this alignment, we performed a blast search in the cat genome and found four CD1A genes of which two contained the nucleotide sequence of the cytoplasmic tail, and we used known CD1a cytoplasmic tail sequences of human (NM001763), rabbit (AF276977 and AF276978), pig (AF059492), and cattle (DQ192541). Except for human CD1a and canCD1a8.2, all other known mammalian CD1a cytoplasmic tails are long. CanCD1a2 and canCD1a8.1 have an even longer cytoplasmic tail of 31 amino acids, which was confirmed by the identification of transcripts of canCD1A8.1 (DN877612) and canCD1A2 (DN409579) that included these cytoplasmic tails in the EST databases. No known sorting motif was observed in any of the canine CD1a cytoplasmic tail sequences. Fig. 5a Alignment of the CD1a cytoplasmic tail sequences of different mammalian species. Tail sequences that were not confirmed by cDNA sequencing but only predicted from the genome are marked accordingly (p). b Alignment of cytoplasmic tail sequences of canCD1b, canCD1c, and canCD1d with their human orthologs. The tyrosine trafficking motif (YXXZ) is underlined
###end p 37
###begin p 38
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 204 205 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 348 358 348 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">underlined</italic>
###xml 290 295 <span type="species:ncbi:9606">human</span>
a Alignment of the CD1a cytoplasmic tail sequences of different mammalian species. Tail sequences that were not confirmed by cDNA sequencing but only predicted from the genome are marked accordingly (p). b Alignment of cytoplasmic tail sequences of canCD1b, canCD1c, and canCD1d with their human orthologs. The tyrosine trafficking motif (YXXZ) is underlined
###end p 38
###begin p 39
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 280 285 <span type="species:ncbi:9606">human</span>
The cytoplasmic tails of the other canine CD1 isoforms were aligned with the amino acid sequences of cytoplasmic tails of their human homologs (Fig. 5b). Like in their human counterparts, the tyrosine trafficking motif YXXZ was present in all three canine sequences. However, the human CD1c tail contains a dileucine motif, which is not present in canCD1c.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2006</xref>
###xml 1263 1267 1263 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">2003</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2005</xref>
The canine CD1 locus located on chromosome 38 contained all known CD1 isoforms. We identified a remarkable large number of CD1A homologs, three of which were shown to be full-length canCD1A genes and five were considered pseudogenes. Intensive duplication of CD1A genes leading to the presence of two or possibly three distinct CD1a proteins is characteristic for the canine CD1 locus. This is the first study showing differential transcription of two CD1A genes for which in vivo protein expression is confirmed. These differences in expression might indicate differences in function between the CD1a molecules in canine skin. So far, it is unknown whether these different CD1a molecules are present on the same antigen-presenting cell in the canine skin or that different antigen-presenting cells express different canCD1a molecules. Stationary epidermal Langerhans cells as well as migrating dermal Langerhans cells have a high CD1a expression. Besides Langerhans cells, also a subpopulation of dermal dendritic cells has been reported to express CD1a (Angel et al. 2006). These professional antigen-presenting cells play an important role in the initiation of the immune response and are able to activate T cells in a CD1a-restricted manner (Pena-Cruz et al. 2003; Kissenpfennig et al. 2005).
###end p 41
###begin p 42
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1996</xref>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">1997</xref>
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">2006</xref>
###xml 1030 1034 1030 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1996</xref>
###xml 84 88 <span type="species:ncbi:9615">dogs</span>
Increased numbers of CD1c+ Langerhans cells have been described in lesional skin of dogs with atopic dermatitis (Olivry et al. 1996, 1997, 2006). In these two studies, the primary monoclonal antibody CA13.9H11 was used to detect canCD1c. However, from our study using 293T cells transfected with the different CD1 isoforms, we know that CA13.9H11 recognizes canCD1a8.2. It is possible that CA13.9H11 recognizes both CD1a8.2 and canCD1c, but we have not been able to demonstrate recognition of canCD1c by this mAb so far. Therefore, it is possible that the reported expression of CD1 on Langerhans cells in lesional canine skin is reflecting expression of canCD1a8 rather than canCD1c. The current assignment of canCD1c being the molecule recognized by anti-canine CA13.9H11 has not been invalidated in this study. However, 293T cells transfected with three different full-length canCD1C transcripts were not recognized by CA13.9H11. The mAb CA9.AG5 has been used to determine canCD1a expression on Langerhans cells (Olivry et al. 1996). In our study, 293T cells transfected with canCD1A6, canCD1A8.2, canCD1B, or the three canCD1C sequences were not recognized by CA9.AG5. It is possible that the mAb CA9.AG5 does not recognize canCD1 but an unknown epitope on canine thymocytes.
###end p 42
###begin p 43
The current study shows the expression of two different types of canine CD1a proteins. We found differences in the ectodomain between the two molecules and the unique presence of two different cytoplasmic tails, which might contribute to a greater scope of glycolipid antigen presentation and improved skin immunity.
###end p 43
###begin p 44
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">2001</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">2007</xref>
###xml 0 7 <span type="species:ncbi:9986">Rabbits</span>
###xml 159 165 <span type="species:ncbi:9986">rabbit</span>
###xml 222 226 <span type="species:ncbi:9615">dogs</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
###xml 1026 1031 <span type="species:ncbi:9606">human</span>
###xml 1068 1073 <span type="species:ncbi:9606">human</span>
###xml 1248 1253 <span type="species:ncbi:9606">human</span>
###xml 1263 1268 <span type="species:ncbi:9606">human</span>
###xml 1409 1414 <span type="species:ncbi:9606">human</span>
Rabbits are the only other mammalian species that are known to have two different CD1a proteins (Hayes and Knight 2001). However, cytoplasmic tails of the two rabbit CD1a proteins show higher sequence identity compared to dogs. Based on the presence of long cytoplasmic tails in all mammalian species other than primates, it is likely that the canCD1A gene encoding a short cytoplasmic tail (canCD1A8.2) is derived from a paralog with a long cytoplasmic tail. Single-nucleotide point mutations may have introduced a stop codon within the long tail sequence resulting in a shorter tail. Indeed, the 31-amino acid-long cytoplasmic tails of canCD1a2 and canCD1a8.1 can be changed into the short, four-amino acid-long cytoplasmic tail like the one in CD1a8.2, by a single point mutation. The cytoplasmic tail of the human CD1a ortholog does not contain any known endosomal targeting sequences (Sugita et al. 2007). However, whether this also holds for CD1a molecules of other mammalian species and whether they traffic like their human counterpart are unknown. Like their human homologs, a tyrosine motif was present in the cytoplasmic tail of canCD1b and canCD1d. This might indicate that these canine CD1 molecules traffic to similar compartments as human CD1b and human CD1d compartments to sample lipid antigens. Canine CD1c also contained a tyrosine-trafficking motif within its cytoplasmic tail, but unlike human CD1c, a dileucine motif was not present.
###end p 44
###begin p 45
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">2002</xref>
###xml 110 120 <span type="species:ncbi:10141">guinea pig</span>
###xml 152 162 <span type="species:ncbi:10141">guinea pig</span>
CD1 gene duplication might be driven by the lack of certain CD1 isoforms. One of the four CD1B genes found in guinea pig seems to replace the loss of a guinea pig CD1A gene (Hiromatsu et al. 2002). The extensive canine CD1A isoform duplication found in this study seems not to be driven by the limited repertoire of other CD1 isoforms because all isoforms are present within the canine CD1 locus. This suggests that for canCD1A, gene duplication was driven by another reason than the replacement of loss of other CD1 isoforms.
###end p 45
###begin p 46
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">1996</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">1997</xref>
###xml 39 43 <span type="species:ncbi:9615">dogs</span>
The presence of multiple CD1A genes in dogs, their differential transcription in healthy skin, and upregulation at least for canCD1a8 during allergic skin diseases (Olivry et al. 1996; 1997) in combination with their potential to present different glycolipid antigens suggest different functions in skin immunity.
###end p 46
###begin p 47
We thank H. van Engelen and A. van der Lee for their technical assistance. The financial support for this study was provided by Royal Canin, France.
###end p 47
###begin p 48
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Declaration</bold>
Declaration I declare that all experiments in this study comply with the current laws of the country in which the experiments were performed.
###end p 48
###begin p 49
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
###xml 48 53 <span type="species:ncbi:9606">human</span>
Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands
###end article-title 51
###begin article-title 52
Electrostatics of nanosystems: application to microtubules and the ribosome
###end article-title 52
###begin article-title 53
CD1 antigen presentation: how it works
###end article-title 53
###begin article-title 54
Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells
###end article-title 54
###begin article-title 55
###xml 119 124 <span type="species:ncbi:9606">human</span>
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family
###end article-title 55
###begin article-title 56
###xml 19 24 <span type="species:ncbi:10090">mouse</span>
CD1 recognition by mouse NK1+ T lymphocytes
###end article-title 56
###begin article-title 57
CD1: antigen presentation and T cell function
###end article-title 57
###begin article-title 58
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens
###end article-title 58
###begin article-title 59
###xml 18 23 <span type="species:ncbi:9606">human</span>
A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6
###end article-title 59
###begin article-title 60
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice
###end article-title 60
###begin article-title 61
###xml 46 56 <span type="species:ncbi:10141">guinea pig</span>
Conservation of a CD1 multigene family in the guinea pig
###end article-title 61
###begin article-title 62
Recognition of lipid antigens by T cells
###end article-title 62
###begin article-title 63
CD1 expression on antigen-presenting cells
###end article-title 63
###begin article-title 64
Molecular interaction of CD1b with lipoglycan antigens
###end article-title 64
###begin article-title 65
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
###end article-title 65
###begin article-title 66
###xml 21 27 <span type="species:ncbi:9986">rabbit</span>
Group 1 CD1 genes in rabbit
###end article-title 66
###begin article-title 67
###xml 20 30 <span type="species:ncbi:10141">guinea-pig</span>
Characterization of guinea-pig group 1 CD1 proteins
###end article-title 67
###begin article-title 68
###xml 43 49 <span type="species:ncbi:9913">bovine</span>
Comparison of CD1 monoclonal antibodies on bovine cells and tissues
###end article-title 68
###begin article-title 69
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens
###end article-title 69
###begin article-title 70
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides
###end article-title 70
###begin article-title 71
Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells
###end article-title 71
###begin article-title 72
###xml 24 29 <span type="species:ncbi:9940">sheep</span>
Characterization of two sheep lymphocyte differentiation antigens, SBU-T1 and SBU-T6
###end article-title 72
###begin article-title 73
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells
###end article-title 73
###begin article-title 74
###xml 62 88 62 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 62 88 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
###end article-title 74
###begin article-title 75
T cell activation by lipopeptide antigens
###end article-title 75
###begin article-title 76
Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta 2-integrin molecules
###end article-title 76
###begin article-title 77
###xml 31 36 <span type="species:ncbi:9606">human</span>
The Acent and Fcent pockets of human CD1b are both required for optimal presentation of lipid antigens to T cells
###end article-title 77
###begin article-title 78
Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis
###end article-title 78
###begin article-title 79
Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis
###end article-title 79
###begin article-title 80
###xml 43 54 <span type="species:ncbi:9615">beagle dogs</span>
Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis
###end article-title 80
###begin article-title 81
Epidermal Langerhans cells efficiently mediate CD1a-dependent presentation of microbial lipid antigens to T cells
###end article-title 81
###begin article-title 82
SWISS-MODEL: an automated protein homology-modeling server
###end article-title 82
###begin article-title 83
Presentation of the same glycolipid by different CD1 molecules
###end article-title 83
###begin article-title 84
Genomic anatomy of a premier major histocompatibility complex paralogous region on chromosome 1q21-q22
###end article-title 84
###begin article-title 85
###xml 64 69 <span type="species:ncbi:9606">human</span>
CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
###end article-title 85
###begin article-title 86
Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs
###end article-title 86
###begin article-title 87
Separate pathways for antigen presentation by CD1 molecules
###end article-title 87
###begin article-title 88
Pathways of CD1 and lipid antigen delivery, trafficking, processing, loading, and presentation
###end article-title 88
###begin article-title 89
A feline homologue of CD1 is defined using a feline-specific monoclonal antibody
###end article-title 89
###begin article-title 90
Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A
###end article-title 90
###begin article-title 91
Molecular mechanism of lipopeptide presentation by CD1a
###end article-title 91

